Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Making jumping genes sit still could be antiaging strategy

Feb. 14, 2019

Rho-associated protein kinase 1/2 inhibitors disclosed by Kadmon

Feb. 12, 2019

PU.1 controls yin and yang of fibrosis

Feb. 6, 2019

U.S. Department of Health & Human Services patents fatty acid derivatives

Jan. 30, 2019

Takeda Pharmaceutical divulges muscarinic M1 receptor PAMs

Jan. 11, 2019

Universite Laval patents IL-6 expression inhibitors

Jan. 8, 2019

Galapagos initiates phase I trial with GLPG-3312

Jan. 7, 2019

Resolvin receptor analogues limit inflammation

Dec. 18, 2018

Anti-inflammatory compositions presented by House Wellness Foods, House Foods Group

Nov. 29, 2018

New anti-inflammation target has similarities, and differences, to PARP

Nov. 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...